The “100 fürs Baselbiet” (1004BB) initiative was launched in November 2019 by the three partners University of Applied Sciences Northwestern Switzerland (Fachhochschule Nordwestschweiz, FHNW), the State Bank of the Canton of Basel-Landschaft (Basellandschaftliche Kantonalbank, BLKB) and the Canton of Baselland. This popular initiative among start-ups in the region has been operational since the beginning of […]
Four promising Swiss start-ups pitched their ventures from the HEMEX Incubator to an online group of investors. LiVET develops and produces rapid molecular point-of-care diagnostic tests for veterinary use. Based on their proprietary platform technology, veterinarians are able to diagnose infectious diseases on-site and within only 30 minutes for up to 16 samples at […]
After the Top 16 was announced by the W.A. De Vigier in March, now the Top 10 finalists for this year’s Award are published. The winners will be announced in early June! We are particularly proud to see our portfolio company Annaida Technologies in the Top 10 and wish them and all the Top 10 Startups […]
2020 Swiss Innovation Challenge – the traditional networking kick-off event for the SIC was held virtually due to COVID-19 crisis on April 2, 2020! Numerous entrepreneurs from Switzerland and other European countries attended the online kick-off for this years challenge. 100 start-ups from all categories will be admitted to the first pitch, but only 50 […]
Inura Medical AG is admitted to participate at the 2020 >>venture>> competition! Inura Medical AG is a Swiss start-up company focused on the development of re-purposed urological products that combine a medical technology consisting of an urethral suppository and a pharmaceutical agent. Its first product offers a rescue therapy to two highly prevalent and disabling […]
Scailyte™ is an ETH Zürich Spin-off and Top100 Swiss Startup applying artificial intelligence to discover novel and ultra-sensitive biomarkers from single-cell data.Over the past 3 years, we have established ScaiVision™, a proprietary data analytics platform for clinical research, which enables us to achieve groundbreaking discoveries in multiple disease areas. We have validated our approach by […]